Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands
Molecules · 2024
DOI: 10.3390/molecules29122759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Claudia C Gatto und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Brasilia, Institute of Chemistry, Laboratory of Inorganic Synthesis and Crystallography, Brasília 70910-900, DF, Brazil. Hauptthemen laut MEDLINE: Nickel, Molecular Docking Simulation, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research Support of the Federal District, National Council for Scientific and Technological Development, FAPDF.
Abstract (Originalsprache)
The current article reports the investigation of three new Ni(II) complexes with ONS-donor dithiocarbazate ligands: [Ni(L1)PPh3] (1), [Ni(L2)PPh3] (2), and [Ni(L2)Py] (3). Single-crystal X-ray analyses revealed mononuclear complexes with a distorted square planar geometry and the metal centers coordinated with a doubly deprotonated dithiocarbazate ligand and coligand pyridine or triphenylphosphine. The non-covalent interactions were investigated by the Hirshfeld surface and the results revealed that the strongest interactions were π⋅⋅⋅π stacking interactions and non-classical hydrogen bonds C–H···H and C–H···N. Physicochemical and spectroscopic methods indicate the same structures in the solid state and solution. The toxicity effects of the free ligands and Ni(II) complexes were tested on the human breast cancer cell line MCF-7 and non-malignant breast epithelial cell line MCF-10A. The half-maximal inhibitory concentration (IC50) values, indicating that the compounds were potent in inhibiting cell growth, were obtained for both cell lines at three distinct time points. While inhibitory effects were evident in both malignant and non-malignant cells, all three complexes demonstrated lower IC50 values for malignant breast cell lines than their non-malignant counterparts, suggesting a stronger impact on cancerous cell lines. Furthermore, molecular docking studies were performed showing the complex (2) as a promising candidate for further therapeutic exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Brasilia, Institute of Chemistry, Laboratory of Inorganic Synthesis and Crystallography, Brasília 70910-900, DF, Brazil.
- University of Brasilia, Institute of Chemistry, Laboratory of Computational Chemistry, Brasília 70910-900, DF, Brazil.
- University of Brasilia, Faculty of Health Sciences and Medicine, Laboratory of Molecular Pathology of Cancer, Brasília 70910-900, DF, Brazil.
ORCID-Profile: Claudia C Gatto, Érica C M Nascimento, João B L Martins, Fabio Pittella-Silva
Förderung
- Foundation for Research Support of the Federal District
- National Council for Scientific and Technological Development
- FAPDF
- CNPq
- UnB
- CAPES
Zitieren
APA
Gatto, C. C., Cavalcante, C. Q. O., Lima, F. C., Nascimento, É. C. M., Martins, J. B. L., Santana, B. L. O., Gualberto, A. C. M., & Pittella-Silva, F. (2024). Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands. Molecules. https://doi.org/10.3390/molecules29122759
Vancouver
Gatto CC, Cavalcante CQO, Lima FC, Nascimento ÉCM, Martins JBL, Santana BLO, et al. Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands. Molecules. 2024. doi:10.3390/molecules29122759
BibTeX
@article{Gatto2024,
author = {Gatto, Claudia C and Cavalcante, Cássia de Q O and Lima, Francielle C and Nascimento, Érica C M and Martins, João B L and Santana, Brunna L O and Gualberto, Ana C M and Pittella-Silva, Fabio},
title = {Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29122759}
}
EUVIMED